We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$551M
AUM Growth
+$31.7M
Cap. Flow
-$16.8M
Cap. Flow %
-3.04%
Top 10 Hldgs %
52.81%
Holding
80
New
3
Increased
18
Reduced
52
Closed
2

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$3.45M
2
RTX icon
RTX Corp
RTX
+$2.99M
3
AAPL icon
Apple
AAPL
+$1.83M
4
NVDA icon
NVIDIA
NVDA
+$1.51M
5
EEFT icon
Euronet Worldwide
EEFT
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 32.97%
2 Healthcare 20.53%
3 Consumer Discretionary 12.38%
4 Communication Services 8.65%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
51
Diageo
DEO
$49B
$1.08M 0.2%
7,374
-1,450
-16% -$214K
QCOM icon
52
Qualcomm
QCOM
$155B
$1.05M 0.19%
7,267
-403
-5% -$49.9K
ABBV icon
53
AbbVie
ABBV
$443B
$1.03M 0.19%
6,661
ADI icon
54
Analog Devices
ADI
$179B
$926K 0.17%
4,653
-165
-3% -$29.5K
ETN icon
55
Eaton
ETN
$161B
$918K 0.17%
3,810
+55
+1% +$12.1K
WMT icon
56
Walmart Inc
WMT
$885B
$911K 0.17%
17,304
ASML icon
57
ASML
ASML
$626B
$886K 0.16%
1,171
+70
+6% +$46.2K
AMGN icon
58
Amgen
AMGN
$208B
$753K 0.14%
2,616
-3
-0.1% -$817
HSY icon
59
Hershey
HSY
$35.2B
$643K 0.12%
3,457
+872
+34% +$165K
UNH icon
60
UnitedHealth
UNH
$376B
$630K 0.11%
1,197
+9
+0.8% +$4.8K
NVS icon
61
Novartis
NVS
$297B
$558K 0.1%
5,523
-402
-7% -$38.8K
K
62
DELISTED
Kellanova
K
$449K 0.08%
8,020
-521
-6% -$27.2K
KO icon
63
Coca-Cola
KO
$377B
$386K 0.07%
6,547
+84
+1% +$4.77K
MRK icon
64
Merck
MRK
$322B
$376K 0.07%
3,451
-145
-4% -$15.1K
TGT icon
65
Target
TGT
$65.6B
$359K 0.07%
2,525
-100
-4% -$12.2K
TTC icon
66
Toro Company
TTC
$8.75B
$332K 0.06%
3,460
-150
-4% -$12.9K
CSCO icon
67
Cisco
CSCO
$457B
$330K 0.06%
6,480
-53
-0.8% -$2.71K
EMR icon
68
Emerson Electric
EMR
$83.9B
$306K 0.06%
3,157
INTC icon
69
Intel
INTC
$455B
$305K 0.06%
6,106
+27
+0.4% +$1.1K
EOG icon
70
EOG Resources
EOG
$79.2B
$294K 0.05%
2,426
-23
-0.9% -$2.86K
MRSH
71
Marsh
MRSH
$90.5B
$284K 0.05%
1,500
AFL icon
72
Aflac
AFL
$64.9B
$274K 0.05%
3,300
LLY icon
73
Eli Lilly
LLY
$1.02T
$264K 0.05%
452
-19
-4% -$11.1K
VLTO icon
74
Veralto
VLTO
$23B
$254K 0.05%
+3,101
New +$232K
UNP icon
75
Union Pacific
UNP
$174B
$221K 0.04%
+900
New +$198K

Similar funds

Dillon & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Dillon & Associates held 80 positions worth $551M, up 6.1% from $520M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Dillon & Associates withdrew a net $16.8M in Q4 2023, closing 2 positions and reducing 52 holdings. Its most notable exit was Pacira BioSciences, an estimated $240K position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Dillon & Associates opened a new position in Rockwell Automation worth $2.51M.

  • Dillon & Associates's largest Q4 2023 buy was Rockwell Automation: 8,095 shares worth $2.51M.
  • Dillon & Associates added most to Paycom in Q4 2023, an estimated $2.07M increase.
  • Dillon & Associates's biggest Q4 2023 reduction was PayPal, cutting an estimated $3.45M.
  • Dillon & Associates fully exited Pacira BioSciences in Q4 2023, selling an estimated $240K.
  • Dillon & Associates's ten largest holdings make up 53% of its $551M portfolio in Q4 2023.
  • Dillon & Associates opened 3 new positions and closed 2 in Q4 2023.
  • Dillon & Associates's portfolio value rose 6.1% quarter-over-quarter to $551M.

Based on Dillon & Associates's 13F filing for Q4 2023, filed 8 Feb 2024.